Marshall Wace’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,646
Closed -$1.56M 3754
2026
Q1
$1.56M Sell
15,646
-174,824
-92% -$22.8M ﹤0.01% 1922
2025
Q4
$23.2M Sell
190,470
-351,208
-65% -$44.1M 0.02% 585
2025
Q3
$60.8M Sell
541,678
-5,109
-0.9% -$598K 0.06% 270
2025
Q2
$73.3M Buy
546,787
+394,340
+259% +$43.3M 0.08% 227
2025
Q1
$10.3M Buy
+152,447
New +$10.5M 0.01% 763
2024
Q3
Sell
-9,452
Closed -$1.42M 2954
2024
Q2
$1.42M Sell
9,452
-251,782
-96% -$30.2M ﹤0.01% 1525
2024
Q1
$19.3M Sell
261,234
-81,021
-24% -$6.68M 0.03% 519
2023
Q4
$27M Sell
342,255
-234,898
-41% -$14.2M 0.05% 388
2023
Q3
$31.6M Buy
+577,153
New +$41.5M 0.06% 304
2022
Q1
Sell
-20,159
Closed -$386K 4022
2021
Q4
$386K Buy
+20,159
New +$505K ﹤0.01% 2933
2021
Q2
Sell
-8,805
Closed -$365K 3093
2021
Q1
$365K Buy
+8,805
New +$271K ﹤0.01% 2061
2020
Q4
Sell
-24,252
Closed -$334K 2174
2020
Q3
$334K Buy
24,252
+9,354
+63% +$160K ﹤0.01% 1340
2020
Q2
$267K Buy
+14,898
New +$233K ﹤0.01% 1352

Other funds holding TMDX

Marshall Wace's TMDX Position: Q2 2026 in Review

Marshall Wace sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 15,646 shares — an estimated $1.56M sold.

Marshall Wace first reported a position in TMDX in Q2 2020 and held it in 13 quarters. The position peaked at $73.3M in Q2 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Marshall Wace reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 15,646 Transmedics shares in Q2 2026, an estimated $1.56M.
  • Marshall Wace first reported a position in Transmedics in Q2 2020 and held it in 13 quarters.
  • Marshall Wace's Transmedics position peaked at $73.3M in Q2 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.